Zobrazeno 1 - 10
of 327
pro vyhledávání: '"JUNJI YONESE"'
Autor:
Itsuko Serizawa, PhD, Takuyo Kozuka, PhD, Takashi Soyano, MD, Kazuma Sasamura, MD, Tatsuya Kamima, Bsc, Hiroaki Kunogi, PhD, Nozomi Kurihara, MPh, Noboru Numao, PhD, Shinya Yamamoto, PhD, Junji Yonese, PhD, Yasuo Yoshioka, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 10, Pp 101612- (2024)
Purpose: This study aimed to compare the outcomes and toxicities between patients treated with image guided radiation therapy (IGRT) using fiducial markers and non-IGRT in intensity modulated radiation therapy (IMRT) for prostate cancer. Methods and
Externí odkaz:
https://doaj.org/article/af8914dc79d5449da64742c425108a7e
Autor:
Ichiro Yonese, Noboru Numao, Kentaro Inamura, Yusuke Yoneoka, Ryo Fujiwara, Yosuke Yasuda, Tomohiko Oguchi, Shinya Yamamoto, Takeshi Yuasa, Junji Yonese
Publikováno v:
IJU Case Reports, Vol 7, Iss 1, Pp 64-67 (2024)
Introduction Recently, perioperative use of immune checkpoint inhibitors has improved the prognosis of muscle‐invasive bladder cancer. It is unclear whether radical cystectomy or systemic pembrolizumab is the optimal next treatment in patients with
Externí odkaz:
https://doaj.org/article/17d7775a14ee47d8ab8bc364c0c96964
Autor:
Minami Une, Ryo Fujiwara, Arisa Ueki, Ryosuke Oki, Tetsuya Urasaki, Kentaro Inamura, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
Publikováno v:
IJU Case Reports, Vol 6, Iss 5, Pp 286-289 (2023)
Introduction Li–Fraumeni syndrome, an autosomal dominant cancer predisposition syndrome caused by a pathogenic variant of TP53, a tumor suppressor gene, leads to a high risk from early childhood of developing various types of cancers. Here, we repo
Externí odkaz:
https://doaj.org/article/19f307c5fcb141499aca3bf099a9e54d
Autor:
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The significance of metastasis-directed therapy for oligometastatic prostate cancer has been widely discussed, and targeted therapy for progressive sites is a feasible option as a multidisciplinary treatment for castration-resista
Externí odkaz:
https://doaj.org/article/a2f96538335345bc92c71087caf16814
Autor:
Nobuaki Matsubara, Junji Yonese, Takahiro Kojima, Haruhito Azuma, Hiroaki Matsumoto, Thomas Powles, Jonathan E. Rosenberg, Daniel P. Petrylak, Maria Matsangou, Chunzhang Wu, Mary Campbell, Mayumi Yamashiro
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2761-2771 (2023)
Abstract Background Enfortumab vedotin (EV) is an antibody‐drug conjugate showing significant overall survival (OS) benefit versus chemotherapy for patients with previously treated locally advanced or metastatic urothelial carcinoma (la/mUC) in EV
Externí odkaz:
https://doaj.org/article/402416e25b934d6ba8bab3a603b2623e
Autor:
Ryosuke Oki, Tetsuya Urasaki, Arisa Ueki, Kentaro Inamura, Yoshinobu Komai, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
Publikováno v:
IJU Case Reports, Vol 6, Iss 1, Pp 33-36 (2023)
Introduction In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial ca
Externí odkaz:
https://doaj.org/article/a12c51cf117b491abd558a48ae8eff90
Autor:
Eri Fukagawa, Takeshi Yuasa, Kentaro Inamura, Kosuke Hamada, Motohiro Fujiwara, Yoshinobu Komai, Junji Yonese
Publikováno v:
IJU Case Reports, Vol 5, Iss 6, Pp 505-510 (2022)
Introduction Prostatic large‐cell neuroendocrine carcinoma is poorly studied. Although several case reports are available, information on the clinicopathological characteristics of this disease is limited, particularly for the de novo (hormone‐na
Externí odkaz:
https://doaj.org/article/aa4745e457054269b9ad8e5e1fe69359
Autor:
Kasumi Kaneko Yoshitomi, Noboru Numao, Yosuke Umino, Motohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Takeshi Yuasa, Shinya Yamamoto, Junji Yonese
Publikováno v:
IJU Case Reports, Vol 4, Iss 5, Pp 285-288 (2021)
Introduction Although the utility of diffusion‐weighted whole‐body imaging with background body signal suppression for assessing lymph node involvement or distant metastasis is renowned in many cancers, only few studies have revealed its utility
Externí odkaz:
https://doaj.org/article/e470d33066844447aba7740bfae756ce
Autor:
Emiko Sugawara, Yasuyuki Shigematsu, Gulanbar Amori, Keisuke Sugita, Junji Yonese, Kengo Takeuchi, Kentaro Inamura
Publikováno v:
Diagnostics, Vol 13, Iss 14, p 2408 (2023)
Female urethral adenocarcinoma has attracted attention as a rare tumor type based on its differential pathogenesis from its male counterpart. However, to date, our knowledge concerning its immunohistochemical and morphological characteristics remains
Externí odkaz:
https://doaj.org/article/c57005ff46da4f54a57d1a90e0a0e60f
Autor:
Akira Yokomizo, Hirofumi Koga, Kazuto Ito, Yutaka Takezawa, Motokiyo Komiyama, Kazuo Nishimura, Junji Yonese, Katsuyoshi Hashine, Naoya Masumori, Gaku Arai, Shiro Saito, Mitsuru Shinohara, Nobuaki Shimizu, Atsushi Yamauchi, Takefumi Satoh, Tatsuo Tochigi, Mikio Kobayashi, Hiroyuki Fujimoto, Ken‐ichi Kakimoto, Iwao Fukui, Taiji Tsukamoto, Miwako Nozaki, Katsuyuki Karasawa, Masaru Hasumi, Mikinobu Ohtani, Hiromichi Ishiyama, Masaaki Kuwahara, Masaoki Harada, Yasuo Ohashi, Toshihiko Kotake, Tadao Kakizoe, Kazuhiro Suzuki, Seiji Naito, Hidetoshi Yamanaka, National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3240-3248 (2021)
Abstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for pati
Externí odkaz:
https://doaj.org/article/4fc6d5a819fc4ff3b13b667c17fde309